Evidence map›Paper›PMID 35809571›Full record

ReviewCell2022

Tools for mammalian glycoscience research.

Matthew E Griffin, Linda C Hsieh-Wilson

Open access · greenAbstract readReview
In one paragraph

Review in Cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 69 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Accurate Identification of Protein Binding Sites for All Drug Modalities Using ALLSites.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Ultradeep O-GlcNAc proteomics reveals widespread O-GlcNAcylation on tyrosine residues of proteins.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  20. Glycoengineering in antigen-specific immunotherapies.Current opinion in chemical biology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Matthew E GriffinDepartment of Chemistry, University of California, Irvine, Irvine, CA 92697, USA; Department of Microbiology and Immunology, Scripps Research, La Jolla, CA 92037, USA.
Linda C Hsieh-WilsonDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125, USA. Electronic address: lhw@caltech.edu.
California Institute of Technology · USScripps Research Institute · US

Funding

SUGAR-seq: A New Technology for Single-Cell Glycan and Gene Expression Profiling in ADRF1AG062324 · NIA · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI HSIEH-WILSON, LINDA C · 2018 to 2018
$3.3M
Expedited Synthesis of Glycosaminoglycans Containing Defined Sulfation DomainsU01GM116262 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI HSIEH-WILSON, LINDA C, HUANG, XUEFEI · 2015 to 2018
$2.8M
Chemical Approaches to Understand the Roles of O-GlcNAc Glycosylation in BiologyRF1AG060540 · NIA · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI HSIEH-WILSON, LINDA C · 2018 to 2018
$2.4M
Evolving New Glycosaminoglycan MimeticsR01GM127920 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI HSIEH-WILSON, LINDA C · 2018 to 2021
$1.5M
NIA NIH HHS RF1 AG060540NIA NIH HHS RF1 AG062324NIGMS NIH HHS R01 GM127920NIGMS NIH HHS U01 GM116262
6 · The paper itself

Abstract

Cellular carbohydrates or glycans are critical mediators of biological function. Their remarkably diverse structures and varied activities present exciting opportunities for understanding many areas of biology. In this primer, we discuss key methods and recent breakthrough technologies for identifying, monitoring, and manipulating glycans in mammalian systems.

Indexed as

CarbohydratesPolysaccharidesAnimalsMammalsCarbohydratesPolysaccharidescarbohydratesglycansglycobiologymammalian biology

Identifiers

PMID35809571
PMCPMC9339253
OpenAlexW4284970719

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.